Alexion
@alexionpharma
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc.
GL/NP/0116
GL/NP/0095
ID: 246664765
https://alexion.com/Documents/Alexion-Community-Guidelines 03-02-2011 06:37:18
1,1K Tweet
12,12K Followers
331 Following
Today, AstraZeneca completed the acquisition of Amolyt Pharma. This acquisition bolsters the Alexion, AstraZeneca Rare Disease pipeline and expands on its bone metabolism franchise as we work to serve more #RareDisease patients around the world.